Melatonin as a prototype of chronobiotic-cytoprotective drugs

dc.creatorCardinali, Daniel P.
dc.date2005-11
dc.date2022-12-07T13:02:17Z
dc.date.accessioned2023-07-15T09:03:15Z
dc.date.available2023-07-15T09:03:15Z
dc.identifierhttp://sedici.unlp.edu.ar/handle/10915/146971
dc.identifierhttps://pmr.safisiol.org.ar/wp-content/uploads/2022/08/vol1_n4_november.pdf
dc.identifierissn:1669-5410
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7486644
dc.descriptionMelatonin provides an innovative neuroprotective strategy by combining its effects on sleep with its cytoprotective properties. Melatonin protects against several mechanisms of neuronal death, including oxyradical-mediated damage and apoptosis implicated in the pathogenesis of a number of neurodegenerative diseases like AD, Parkinsonism, Huntington’s chorea and neurological conditions like stroke, epilepsy and brain trauma.
dc.descriptionSociedad Argentina de Fisiología
dc.formatapplication/pdf
dc.languagees
dc.rightshttp://creativecommons.org/licenses/by/4.0/
dc.rightsCreative Commons Attribution 4.0 International (CC BY 4.0)
dc.subjectCiencias Médicas
dc.subjectFisiología
dc.subjectMelatonin
dc.subjectCytoprotective properties
dc.titleMelatonin as a prototype of chronobiotic-cytoprotective drugs
dc.typeArticulo
dc.typeRevision


Este ítem pertenece a la siguiente institución